PerkinElmer expands newborn health screening with new acquisition

PerkinElmer has acquired Pediatrix’s metabolic screening laboratory in a cash transaction.

The company has also purchased the StepOne newborn screening process that can analyse more than 50 inherited disorders in newborns.

Gregory Summe, chairman and chief executive officer of PerkinElmer, said: "This announcement builds on our strategy to expand the capabilities of our Genetic Screening business to protect the health of mothers and babies from pregnancy to birth and beyond,"

"PerkinElmer is building an enhanced capability to deliver a growing portfolio of world-class neonatal and prenatal/maternal health solutions to consumers through their healthcare professionals."

PerkinElmer and Pediatrix intend to collaborate on future research to identify possible applications for tandem mass spectrometry technology in prenatal and neonatal testing.

As a technology leader in the health sciences and photonics market, PerkinElmer claims to combine operational excellence and technology expertise.